SPHK1 and ovarian carcinoma: Mechanistically, metformin decreases the proliferation, migration, and invasion of patient-derived ovarian cancer cells [164,165] by decreasing sphingosine kinase-1 (SPHK) expression and reducing serum sphingosine-1 phosphate (S1P) levels.